Related Experiment Video

Updated: Aug 16, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma

K Ganter1, K A Deichmann, A Heinzmann

  • 1University Children's Hospital, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany.

International Journal of Immunogenetics
|July 20, 2005
PubMed

Insights

Genetic variations in the matrix metalloproteinase 9 (MMP-9) gene were not linked to childhood asthma. These findings suggest MMP-9 may not be a primary genetic factor in asthma development.

Area of Science:

  • Genetics
  • Immunology
  • Respiratory Medicine

Background:

  • Matrix metalloproteinase 9 (MMP-9) is implicated in the pathogenesis of bronchial asthma.
  • Understanding the genetic basis of asthma is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the association between specific matrix metalloproteinase 9 (MMP-9) gene polymorphisms and asthma in a pediatric cohort.
  • To determine if MMP-9 gene variations contribute to asthma susceptibility.

Main Methods:

  • Genotyping was performed for four MMP-9 gene polymorphisms: -T1702A, -C1562T, R279Q, and +C6T.
  • A case-control study was conducted involving 231 children diagnosed with asthma.

Main Results:

  • No statistically significant association was found between the studied MMP-9 gene polymorphisms and asthma.
  • The investigated genetic variations in MMP-9 did not appear to influence asthma risk in the studied population.

Conclusions:

  • The matrix metalloproteinase 9 (MMP-9) gene, specifically the examined polymorphisms, may not be a major genetic determinant of asthma.
  • Further research into other genetic factors influencing asthma development is warranted.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...